Mahmoud Mona F, Ali Noura, Mostafa Islam, Hasan Rehab A, Sobeh Mansour
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Antioxidants (Basel). 2022 Feb 23;11(3):441. doi: 10.3390/antiox11030441.
In the present study, we aimed to investigate the effect of coriander oil on dexamethasone-induced insulin resistance in rats and characterize its chemical composition using gas chromatography-mass spectrometry (GC-MS). Rats were divided into five groups ( = 6): Normal control, insulin resistance (IR) control, IR + metformin (50 mg/kg/day, PO, Per Oral), IR + coriander oil low dose (0.5 mL/kg, PO), and IR + coriander oil high dose (1 mL/kg, PO). IR groups were injected with a dose of 10 mg/kg dexamethasone subcutaneously for four consecutive days. All groups received either vehicle or drugs daily for four days. Animal weights and pancreatic weights were measured, and oral glucose tolerance test was performed at the end of study. Fasting glucose, triglycerides (TG), total cholesterol (TC), HDL and insulin levels in serum, MDA, and GSH levels in pancreatic tissue were measured and HOMA-IR was calculated. Immunoexpression of apoptosis markers BAX, and BCL2 was measured in pancreatic tissues and BAX/BCL2 ratio was calculated. Histopathological examination of pancreatic tissues was also performed. Pancreatic weight, serum HDL, pancreatic GSH, and BCL2 were decreased while serum glucose, insulin, TG, TC levels, AUC of OGGT, HOMA-IR, pancreatic MDA, BAX, and BAX/BCL2 ratio were increased in IR rats. Histopathological examination showed congestion, vacuolation and hemorrhage in pancreatic islets. These changes were reversed by metformin and the high dose of coriander oil treatments. The obtained activities could be attributed to the presence of 21 volatile compounds, identified by GC-MS. Our study indicates that coriander oil can be used as an adjuvant antihyperglycemic agent in type 2 diabetes. Further experiments are needed to determine the therapeutic dose and the treatment time.
在本研究中,我们旨在研究芫荽油对大鼠地塞米松诱导的胰岛素抵抗的影响,并使用气相色谱 - 质谱联用仪(GC - MS)对其化学成分进行表征。将大鼠分为五组(每组n = 6):正常对照组、胰岛素抵抗(IR)对照组、IR +二甲双胍(50 mg/kg/天,口服)组、IR +低剂量芫荽油(0.5 mL/kg,口服)组和IR +高剂量芫荽油(1 mL/kg,口服)组。IR组连续四天皮下注射剂量为10 mg/kg的地塞米松。所有组每天接受载体或药物处理,持续四天。测量动物体重和胰腺重量,并在研究结束时进行口服葡萄糖耐量试验。测量血清中的空腹血糖、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白(HDL)和胰岛素水平,胰腺组织中的丙二醛(MDA)和谷胱甘肽(GSH)水平,并计算胰岛素抵抗指数(HOMA - IR)。测量胰腺组织中凋亡标志物BAX和BCL2的免疫表达,并计算BAX/BCL2比值。还对胰腺组织进行了组织病理学检查。IR大鼠的胰腺重量、血清HDL、胰腺GSH和BCL2降低,而血清葡萄糖、胰岛素、TG、TC水平、口服葡萄糖耐量试验(OGGT)的曲线下面积(AUC)、HOMA - IR、胰腺MDA、BAX和BAX/BCL2比值升高。组织病理学检查显示胰岛充血、空泡化和出血。这些变化通过二甲双胍和高剂量芫荽油治疗得以逆转。通过GC - MS鉴定出的21种挥发性化合物可能是所观察到的活性的原因。我们的研究表明,芫荽油可作为2型糖尿病的辅助降血糖药物。需要进一步的实验来确定治疗剂量和治疗时间。